Bartek, I. T., Holden, M. P., and Ionescu, M. L. (1974) . Thorax, 29, [51] [52] [53] [54] [55] Frame-mounted tissue heart valves: technique of construction. The technical details for the construction and preservation of frame-mounted tissue heart valves are described. The results of clinical and experimental work which have prompted changes and improvements in valve construction are briefly discussed.
Since the first frame-mounted fascia lata heart valves were used clinically (Ionescu and Ross, 1969) , over 260 tissue valves made of autologous or homologous fascia lata or of heterologous pericardium have been inserted at this institution in the mitral, aortic, and tricuspid positions.
Encouraged by our results, especially with aortic valve replacement, over more than four and a half years , we continue the clinical and laboratory testing and evaluation of frame-mounted tissue valves. The experience so far has shown that one important factor on which the long-term function of these valves depends is their perfect construction before insertion (Swales, Holden, Dowson, and Ionescu, 1973) .
The technical details for the manufacture and preservation of stented tissue valves are described in this paper. The changes and improvements in construction consequent upon the clinical and laboratory results are discussed.
TECHNIQUES OF VALVE CONSTRUCTION
The tissues used clinically in our department have been fascia lata and bovine pericardium. With the exception of four cases in which free fascial grafts were used for aortic replacement at the beginning of our experience, all tissue valves were attached to a support frame.
For simplicity the construction of pericardial valves will be described, THE FRAME The supporting frame consists of a thinwalled, scallop-shaped titanium ring with three narrow Correspondence to: M. I. Ionescu, Department of Cardiothoracic Surgery, The General Infirmary, Leed prongs placed at equal distances around the circumference. The ring and prongs are perforated to allow the passage of sutures. The entire frame is covered with a thin layer of woven Dacron velour.
A separate ring of reinforced Silastic, covered on both sides with Dacron velouil is used for attaching the tissue valve to the heart valve annulus (Fig. 1) For attenuation of the antigenic potential and for sterilization and fixation of the pericardial tissue, the method described by Carpentier and Dubost (1972) is used. The strips of pericardium are placed in Hanks' solution for at least three hours. The tissue is then transferred to a solution of 1 part 3% sodium metaperiodate and 2 parts Hanks' solution and maintained for 24 hours. Next, the tissue is placed for one hour in 1% ethylene glycol in Hanks' solution and is finally transferred in a glutaraldehyde solutionl in which it is kept for from two to six weeks.
After 10 to 14 days' fixation in glutaraldehyde the tissue is mounted on the frame and the valve is left in freshly prepared glutaraldehyde solution for another period of one to four weeks after which it is inspected and finally transferred in a solution of buffered (pH 5-6) 4% formaldehyde until used. All solutions used for the treatment of the tissue are filtered through Millipore filters G.S., sterilized, and kept continuously at 40 C.
The strips of pericardium are immersed in the different solutions by suspension in special containers in such a way that they are continuously bathed by the solution. During the whole process of chemical treatment the containers with the tissue are kept in the dark at 40 C. cONSTRUCTION OF VALVES A prepared piece of pericardium is tailored to the required size (Table) . The free margins of the short sides are sewn together for 4 mm, using a double, continuous 4-0 Mersilene suture, thus producing a partially completed cylinder ( Fig. 2A) . The smooth visceral surface of the pericardium becomes the inflow side for atrioventricular valves and the outflow side for aortic valves.
The upper end of the cylinder, which becomes the free edge of the valve cusps, is marked at three equidistant points with 5-0 sutures. These points are determined by placing the cylinder of tissue on a graduated Teflon cone. This manoeuvre is repeated several times in order to establish with great accuracy these points. One of the three points is the original suture line of Figure 2A The apposition of the free margins of the cusps should be perfect at this stage. Three millimetres depth of apposition of the free margin is adequate to produce competence under physiological pressure.
To allow creation of the ideal shape of the cusps, the pericardium is incised vertically at the commissures, as far as the original commissural stitch (Fig. 4B) . The cusps are allowed to assume their definitive shape without any digital pressure. The base or inflow margin of the tissue is then sutured to the ring of the frame by a continuous running stitch (Figs. 4B and 5 ). The suture continues round the full circumference of the valve to include all three cusps. This suture line is repeated and at the same time the commissural incisions are carefully closed (Fig. 6A ). Finally, a vertical running stitch is inserted which passes through the perforations of the prongs, the pericardium, and the Teflon strip ( Figs 6B and 7) .
The redundant tissue at the inflow margin of the valve, below the frame, is removed, and the Dacron skirt is attached to the valve by a continuous suture Ivan T. Bartek, Michael P. Holden, and Marian 1. (Ionescu et al., 1972; Swales et al., 1973; Holden, Pohlner, Catchpole, and Ionescu, 1974 It is an established engineering principle that a sphere or part of a sphere represents the greatest resistance that can be applied against an opposing force. For this reason the cusp profile is made flatter and the angle between the cusp and the supporting frame greater than 45°, thus offering less resistance to flow.
In order to prevent changes in the geometry of the cusps during valve insertion, the suturing rim of the valve is attached to the frame-mounted tissue after completion of the valve.
The durability of preserved, frame-mounted, heterologous pericardial valves will be established after prolonged periods of clinical follow-up. Our two-and-a-half years' experience with this type of 'bioprosthesis' has been encouraging. None of the 68 pericardial grafts inserted in the aortic (42), mitral (23), and tricuspid (3) position has shown any sign of failure or dysfunction.
